Literature DB >> 14745497

Yeast Golgi apparatus--dynamics and sorting.

A Nakano1.   

Abstract

The yeast Saccharomyces cerevisiae is one of the best-studied organisms to understand molecular mechanisms of membrane traffic, but as far as the organization of the Golgi apparatus is concerned, yeast is only just beginning to yield clues about how dynamic and flexible the organelle is.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14745497     DOI: 10.1007/s00018-003-3356-5

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  22 in total

1.  Is lactate a reliable indicator of tissue hypoxia in the neonatal period?

Authors:  O D Saugstad
Journal:  Acta Paediatr       Date:  2002       Impact factor: 2.299

2.  Serum lactates correlate with mortality after operations for complex congenital heart disease.

Authors:  I M Cheifetz; F H Kern; S R Schulman; W J Greeley; R M Ungerleider; J N Meliones
Journal:  Ann Thorac Surg       Date:  1997-09       Impact factor: 4.330

3.  Initial postoperative serum lactate levels predict survival in children after open heart surgery.

Authors:  L B Siegel; H J Dalton; J H Hertzog; R A Hopkins; R L Hannan; G J Hauser
Journal:  Intensive Care Med       Date:  1996-12       Impact factor: 17.440

4.  Serial blood lactate measurements predict early outcome after neonatal repair or palliation for complex congenital heart disease.

Authors:  J R Charpie; M K Dekeon; C S Goldberg; R S Mosca; E L Bove; T J Kulik
Journal:  J Thorac Cardiovasc Surg       Date:  2000-07       Impact factor: 5.209

5.  Lactacidosis in the neonate is minimized by prenatal detection of congenital heart disease.

Authors:  P M Verheijen; L A Lisowski; P Stoutenbeek; J F Hitchcock; G B W E Bennink; E J Meijboom
Journal:  Ultrasound Obstet Gynecol       Date:  2002-06       Impact factor: 7.299

Review 6.  Neonates with congenital heart disease.

Authors:  P C Laussen
Journal:  Curr Opin Pediatr       Date:  2001-06       Impact factor: 2.856

Review 7.  Neurologic complications of cardiac disease in the newborn.

Authors:  A J du Plessis
Journal:  Clin Perinatol       Date:  1997-12       Impact factor: 3.430

8.  Factors influencing the outcome of congenital heart disease detected prenatally.

Authors:  G K Sharland; S M Lockhart; S K Chita; L D Allan
Journal:  Arch Dis Child       Date:  1991-03       Impact factor: 3.791

Review 9.  Recognition and prevention of neurological complications in pediatric cardiac surgery.

Authors:  F J Kirkham
Journal:  Pediatr Cardiol       Date:  1998 Jul-Aug       Impact factor: 1.655

10.  What happens to children with retarded speech at 3? Longitudinal study of a sample of normal infants up to 20 years of age.

Authors:  G Klackenberg
Journal:  Acta Paediatr Scand       Date:  1980-09
View more
  4 in total

1.  ARL1 plays a role in the binding of the GRIP domain of a peripheral matrix protein to the Golgi apparatus in plant cells.

Authors:  Giovanni Stefano; Luciana Renna; Sally L Hanton; Laurent Chatre; Thomas A Haas; Federica Brandizzi
Journal:  Plant Mol Biol       Date:  2006-06       Impact factor: 4.076

2.  ER - the key to the highway.

Authors:  Giovanni Stefano; Chris Hawes; Federica Brandizzi
Journal:  Curr Opin Plant Biol       Date:  2014-09-26       Impact factor: 7.834

3.  Mutations in a highly conserved region of the Arf1p activator GEA2 block anterograde Golgi transport but not COPI recruitment to membranes.

Authors:  Sei-Kyoung Park; Lisa M Hartnell; Catherine L Jackson
Journal:  Mol Biol Cell       Date:  2005-06-01       Impact factor: 4.138

4.  Protein folding and conformational stress in microbial cells producing recombinant proteins: a host comparative overview.

Authors:  Brigitte Gasser; Markku Saloheimo; Ursula Rinas; Martin Dragosits; Escarlata Rodríguez-Carmona; Kristin Baumann; Maria Giuliani; Ermenegilda Parrilli; Paola Branduardi; Christine Lang; Danilo Porro; Pau Ferrer; Maria Luisa Tutino; Diethard Mattanovich; Antonio Villaverde
Journal:  Microb Cell Fact       Date:  2008-04-04       Impact factor: 5.328

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.